drugset / Trial / NCT06561035
ACL-R Opioid Sparing Study
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized control trial to investigate the effectiveness of a multimodal opiate sparing analgesic regimen in controlling post-operative pain and potentially reduce post-operative opioid consumption in patients undergoing Anterior Cruciate Ligament Reconstruction (ACL-R).
Timeline
- Start
- 2024-09-01
- Primary completion
- 2025-08
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diclofenac | Other / unclassified | 75 mg | — |
| Subject | Methylprednisolone | Other / unclassified | — | — |
| Background | Acetaminophen | Small molecule | 1000 mg | — |
| Background | Aspirin | Small molecule | — | — |
| Background | Docusate Sodium | Unknown | — | — |
| Background | Gabapentin | Small molecule | 100 mg | — |
| Background | Methocarbamol | Small molecule | 750 mg | — |
| Background | Oxycodone | Other / unclassified | 5 mg | — |
| Background | Promethazine | Small molecule | 25 mg | — |
| Background | Sennosides | Unknown | — | — |
| Background | Tramadol | Other / unclassified | 50 mg | — |
Indications
No indication recorded.